Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 48
Filtrar
1.
Am Health Drug Benefits ; 14(1): 22-28, 2021 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-33841622

RESUMO

BACKGROUND: The purchase of prescription medications via the Internet is a global phenomenon with significant economic, social, and health-related impacts. The growth of online purchasing of prescription medicines is significant and has been amplified by social isolation related to the COVID-19 pandemic, with many patients unable to obtain medicines as they normally would. By contrast, there are licensed, certified, legitimate retail pharmacies that provide significant and vital services to patients. OBJECTIVE: To review the major public health threat from illegal entities that sell any type of prescription medicines to individuals without proper physician oversight. DISCUSSION: Rogue and inappropriate online vendors are providing counterfeit and substandard medications fraudulently with untold impacts on morbidity and mortality globally. This article presents the differentiation between the types of legal and illegal Internet pharmacies, as well as the actions that are currently in play to affect the illegal online purchase of prescription medicines. Much must be done in a collaborative, global effort to address the public health threat of obtaining prescription drugs via the Internet. CONCLUSION: Global, federal, state, health professional, societal, and patient-specific collaborations are necessary to affect the significant threat that is now present via the increasing ease of access to online medication purchases.

2.
Pharmacotherapy ; 38(6): 651-662, 2018 06.
Artigo em Inglês | MEDLINE | ID: mdl-29637590

RESUMO

The National Academies of Sciences, Engineering, and Medicine has found substantial evidence that cannabis (plant) is effective for the treatment of chronic pain in adults, and moderate evidence that oromucosal cannabinoids (extracts, especially nabiximols) improve short-term sleep disturbances in chronic pain. The paradoxical superiority of the cannabis plant over cannabinoid molecules represents a challenge for the medical community and the established processes that define modern pharmacy. The expanding and variable legalization of cannabis in multiple states nationwide represents an additional challenge for patients and the medical community because recreational and medicinal cannabis are irresponsibly overlapped. Cannabis designed for recreational use (containing high levels of active ingredients) is increasingly available to patients with chronic pain who do not find relief with current pharmacologic entities, which exposes patients to potential harm. This article analyzes the available scientific evidence to address controversial questions that the current state of cannabis poses for health care professionals and chronic pain patients and sets the basis for a more open discussion about the role of cannabis in modern medicine for pain management. A critical discussion on these points, the legal status of cannabis, and considerations for health care providers is presented.


Assuntos
Dor Crônica/tratamento farmacológico , Maconha Medicinal/uso terapêutico , Canabinoides/uso terapêutico , Cannabis , Dronabinol/análise , Humanos , Uso da Maconha/efeitos adversos , Maconha Medicinal/efeitos adversos , Maconha Medicinal/análise , Maconha Medicinal/farmacologia
8.
J Patient Saf ; 9(3): 129-33, 2013 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23965834

RESUMO

OBJECTIVE: Although error-reporting systems enable hospitals to accurately track safety climate through the identification of adverse events, these systems may be underused within a work climate of poor communication. The objective of this analysis is to identify the extent to which perceived communication climate among hospital pharmacists impacts medical error reporting rates. METHODS: This cross-sectional study used survey responses from more than 5000 pharmacists responding to the 2010 Hospital Survey on Patient Safety Culture (HSOPSC). Two composite scores were constructed for "communication openness" and "feedback and about error," respectively. Error reporting frequency was defined from the survey question, "In the past 12 months, how many event reports have you filled out and submitted?" Multivariable logistic regressions were used to estimate the likelihood of medical error reporting conditional upon communication openness or feedback levels, controlling for pharmacist years of experience, hospital geographic region, and ownership status. RESULTS: Pharmacists with higher communication openness scores compared with lower scores were 40% more likely to have filed or submitted a medical error report in the past 12 months (OR, 1.4; 95% CI, 1.1-1.7; P = 0.004). In contrast, pharmacists with higher communication feedback scores were not any more likely than those with lower scores to have filed or submitted a medical report in the past 12 months (OR, 1.0; 95% CI, 0.8-1.3; P = 0.97). CONCLUSIONS: Hospital work climates that encourage pharmacists to freely communicate about problems related to patient safety is conducive to medical error reporting. The presence of feedback infrastructures about error may not be sufficient to induce error-reporting behavior.


Assuntos
Comunicação , Relações Interprofissionais , Erros Médicos/prevenção & controle , Segurança do Paciente , Farmacêuticos/psicologia , Adulto , Estudos Transversais , Coleta de Dados , Hospitais , Humanos , Pacientes Internados , Masculino , Farmacêuticos/estatística & dados numéricos , Inquéritos e Questionários
10.
Am J Pharm Educ ; 77(1): 4, 2013 Feb 12.
Artigo em Inglês | MEDLINE | ID: mdl-23460755

RESUMO

Every discipline within fields of research has instituted guidelines and templates for research endeavors and subsequent publications of findings, with the ultimate result being an increase in quality and acceptance by researchers within and across disciplines. These significant efforts are by nature ongoing, as well they should. These enhancements and guideline developments have been instituted in basic science disciplines, clinical pharmacy, and pharmacy administration relevant and related to subsequent scholarly publication of research findings. Specific research endeavors have included bench research, clinical trials and randomized clinical trials, meta analyses, outcomes research, and large scale database analyses. A similar need for quality and standardization also exists for survey research and scholarship. The purpose of this paper is to clarify why this is important and crucial for the Journal and our academy.


Assuntos
Coleta de Dados/normas , Educação em Farmácia/normas , Projetos de Pesquisa/normas , Faculdades de Farmácia/normas , Viés , Currículo/normas , Políticas Editoriais , Fidelidade a Diretrizes , Guias como Assunto , Humanos , Publicações Periódicas como Assunto , Controle de Qualidade , Tamanho da Amostra , Estados Unidos
16.
Am J Pharm Educ ; 76(10): 195, 2012 Dec 12.
Artigo em Inglês | MEDLINE | ID: mdl-23275660

RESUMO

OBJECTIVES: To compare the elective courses offered by US colleges and schools of pharmacy to establish a benchmark for individual colleges and schools to use in assessing whether they offer a sufficient amount and variety of electives. METHODS: Internet Web sites of US doctor of pharmacy (PharmD) programs were reviewed to identify the number of elective lecture-based courses and elective advanced pharmacy practice experiences (APPE) offered and required. Elective courses were grouped into categories to determine the variety of offerings. RESULTS: Pharmacy students were required to complete a mean of 7 hours of classroom-based elective courses. Thirty-two lecture-based elective courses were offered per college or school, and the mean number of categories of courses offered was 24. An average of 3 required APPEs was offered within 24 categories. CONCLUSIONS: Pharmacy programs varied in the number of and requirements for elective courses. Most elective courses expanded on what was taught in the required curriculum vs informing on unique concepts or skills.


Assuntos
Currículo , Educação em Farmácia/métodos , Faculdades de Farmácia/organização & administração , Estudantes de Farmácia , Humanos , Faculdades de Farmácia/normas
20.
Int J Pharm Pract ; 19(3): 214-6, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21554448

RESUMO

Obesity and overweight is a continuing public health crisis. This health threat respects no boundaries or economic strata, and is a pervasive universal threat with short- and long-term negative sequelae associated. Pharmacists and other health professionals need to structure interventions from individual patient and population-based standpoints. Documentation of effects of programmes needs to be disseminated and incorporated into educational, research and practice-based efforts.


Assuntos
Obesidade/epidemiologia , Sobrepeso/epidemiologia , Saúde Pública , Humanos , Obesidade/economia , Sobrepeso/economia , Assistência Farmacêutica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...